Sponsor

Legacy Health System

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Legacy Health System appears in 19 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials19
Recruiting shown1
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

19 shown
Concurrent Neoadjuvant Chemo/Endocrine Therapy in HER2+ Breast CancerNCT07506876 · lead sponsor · 2026-04-27
RECRUITING
Effects of HBO on Glucose in Patients With DMNCT04261738 · lead sponsor · 2022-09-02
TERMINATED
Acute Post-Radiation Hyperbaric Oxygen (HBO2) for Breast Cancer Patients Who Have Recently Completed Radiation TherapyNCT03916068 · lead sponsor · 2019-07-01
TERMINATED
The Use of Pycnogenol® to Alleviate Menopausal Symptoms Induced or Increased by Breast and Gynecological Cancer TreatmentsNCT03704454 · lead sponsor · 2018-10-01
UNKNOWN
Artificial Pancreas Control System in an Outpatient SettingNCT01871870 · lead sponsor · 2013-05-01
COMPLETED
Artificial Pancreas Control System in an Inpatient SettingNCT01552603 · lead sponsor · 2012-03-01
COMPLETED
Physiologic Response to Glucagon at Varying Insulin LevelsNCT01483651 · lead sponsor · 2011-11-01
COMPLETED
Safety Study of Repeated Doses of Glucagon on Animal Starch in the LiverNCT01986231 · lead sponsor · 2011-01-01
COMPLETED
Real-time Adaptation to Changes in Insulin SensitivityNCT01261052 · lead sponsor · 2010-11-01
COMPLETED
Prevention of Capsular Contracture Using Trental and Vitamin ENCT01082003 · lead sponsor · 2009-10-01
UNKNOWN
Continuous Glucose Monitoring to Measure Effect of Glycemic IndexNCT01145547 · lead sponsor · 2009-04-01
COMPLETED
Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin AloneNCT00797823 · lead sponsor · 2008-11-01
COMPLETED
Trial of Blue Citrus Compared to Placebo in Patients Receiving Aromatase Inhibitor Therapy for Estrogen Receptor Positive Post-Menopausal Breast CancerNCT00702858 · lead sponsor · 2008-04-01
COMPLETED
Acupuncture in the Management of Post Operative Symptoms in Breast Cancer PatientsNCT00419822 · lead sponsor · 2006-09-01
COMPLETED
Determinants of Compliance With Glaucoma TherapyNCT01484392 · lead sponsor · 2006-08-01
COMPLETED
The Comparative Effectiveness of Telemedicine to Detect Diabetic RetinopathyNCT01364129 · lead sponsor · 2006-08-01
COMPLETED
Randomized Controlled Trial of Laparoscopic Gastric Bypass Plus Omentectomy Versus Laparoscopic Gastric Bypass Alone in Improving Diabetic IndicesNCT00552942 · lead sponsor · 2006-07-01
UNKNOWN
Androgen Therapy for Management of Estrogen/Progesterone Receptor Negative ER(-)PR(-) Metastatic Breast CancerNCT00303615 · lead sponsor · 2005-06-01
TERMINATED
Appetite Suppression / Hormone Study Control GroupNCT02029677 · collaborator · 2008-09-01
UNKNOWN

Drugs studied in this sponsor's trials

6 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Legacy Health System as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
glucagon3
placebo2
anastrozole 1 MG1
fluoxymesterone 10 MG1
insulin, regular, human1
pentoxifylline1

Sponsor roles

lead sponsor18
collaborator1
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.